共 50 条
- [2] Preclinical safety evaluation of biotechnology-derived products: Specific aspects [J]. THERAPIE, 2003, 58 (02): : 139 - 143
- [3] Preclinical safety testing of biotechnology-derived pharmaceuticalsUnderstanding the issues and addressing the challenges [J]. Molecular Biotechnology, 2004, 27 : 59 - 74
- [5] REGULATORY CONSIDERATIONS FOR PRODUCTS DERIVED FROM THE NEW BIOTECHNOLOGY [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 188 (AUG): : 12 - MBTD
- [7] NOTES TO APPLICANTS FOR MARKETING AUTHORIZATIONS ON THE PRE-CLINICAL BIOLOGICAL SAFETY TESTING OF MEDICINAL PRODUCTS DERIVED FROM BIOTECHNOLOGY (AND COMPARABLE PRODUCTS DERIVED FROM CHEMICAL SYNTHESIS) [J]. JOURNAL OF BIOLOGICAL STANDARDIZATION, 1989, 17 (03): : 203 - 212
- [8] Risk communication related to animal products derived from biotechnology [J]. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2005, 24 (01): : 141 - 148
- [9] Analytical methods for testing biotechnology products [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
- [10] MEDICINAL PRODUCTS DERIVED THROUGH BIOTECHNOLOGY [J]. BRITISH VETERINARY JOURNAL, 1987, 143 (06): : 487 - 488